Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk E Smith

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|October 19, 2010
The biological paths of IL-1 family members IL-18 and IL-33Dirk E Smith
Nature Reviews. Immunology|January 19, 2010
The IL-1 family: regulators of immunityJohn E Sims, Dirk E Smith
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cellsZoulfia Allakhverdi, Dirk E Smith, Michael R Comeau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2011
Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1 receptor accessory proteinYangyang Huang, Dirk E Smith, Osvaldo Ibáñez-Sandoval, et al.
Genomics|May 7, 2002
Genomic organization of the interleukin-1 locusScott L Taylor, Blair R Renshaw, Kirsten E Garka, et al.
International Immunology|June 14, 2008
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cellsMolly D Smithgall, Michael R Comeau, Bo-Rin Park Yoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookwormsLi-Yin Hung, Ian P Lewkowich, Lucas A Dawson, et al.
The Journal of Biological Chemistry|October 3, 2002
A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptorDirk E Smith, Randal R Ketchem, Heather Moore, et al.
Cytokine|May 3, 2008
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33Gaby Palmer, Brian P Lipsky, Molly D Smithgall, et al.
Immunity, Inflammation and Disease|September 30, 2015
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signalingPraxedis Martin, Gaby Palmer, Emiliana Rodriguez, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|October 19, 2010
The biological paths of IL-1 family members IL-18 and IL-33Dirk E Smith
Nature Reviews. Immunology|January 19, 2010
The IL-1 family: regulators of immunityJohn E Sims, Dirk E Smith
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cellsZoulfia Allakhverdi, Dirk E Smith, Michael R Comeau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2011
Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1 receptor accessory proteinYangyang Huang, Dirk E Smith, Osvaldo Ibáñez-Sandoval, et al.
Genomics|May 7, 2002
Genomic organization of the interleukin-1 locusScott L Taylor, Blair R Renshaw, Kirsten E Garka, et al.
International Immunology|June 14, 2008
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cellsMolly D Smithgall, Michael R Comeau, Bo-Rin Park Yoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookwormsLi-Yin Hung, Ian P Lewkowich, Lucas A Dawson, et al.
The Journal of Biological Chemistry|October 3, 2002
A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptorDirk E Smith, Randal R Ketchem, Heather Moore, et al.
Cytokine|May 3, 2008
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33Gaby Palmer, Brian P Lipsky, Molly D Smithgall, et al.
Immunity, Inflammation and Disease|September 30, 2015
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signalingPraxedis Martin, Gaby Palmer, Emiliana Rodriguez, et al.
Pageof 3